Literature DB >> 10429981

Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.

S Lu1, J Tiekso, S Hietanen, K Syrjänen, V K Havu, S Syrjänen.   

Abstract

A series of 120 biopsies from benign (verruca vulgaris and keratoacanthoma), premalignant (actinic keratosis and extragenital Bowen's disease) and malignant (squamous cell carcinoma) skin lesions were studied immunohistochemically for the expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67. The presence of human papillomavirus (HPV) DNA in these samples had been analysed previously using in situ hybridization (ISH) and PCR. Moderate to intense expression of both PCNA and Ki-67 was present in most of the lesions studied. PCNA staining was extensive in the epidermis underneath the layers where abundant HPV DNA staining was shown in HPV DNA-positive verrucas. In keratoacanthomas, p21 and PCNA expression remained low, despite intense p53 expression. In actinic keratosis, only half of the specimens showed overexpression of p53 associated with moderate or intense expression of PCNA. In extragenital Bowen's lesions, all these cell-cycle markers were overexpressed, but in squamous cell carcinomas, they were heterogeneously expressed and showed no correlation with tumour differentiation. Our results suggest a mechanism by which HPV can reactivate the host genes (leading to cell proliferation) to support its own DNA replication. Also p21 might start keratinocyte differentiation in areas where HPV DNA replication starts. Cell proliferation remained active in actinic keratosis and Bowen's lesions, emphasizing the precancer character of these lesions in contrast with the benign nature of keratoacanthoma and verruca vulgaris.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10429981     DOI: 10.1080/000155599750010634

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study.

Authors:  Recep Bedir; Hasan Güçer; İbrahim Şehitoğlu; Cüneyt Yurdakul; Pelin Bağcı; Pelin Üstüner
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

2.  RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma.

Authors:  Jessica C Hassel; Leopold Groesser; Eva Herschberger; Wilko Weichert; Christian Hafner
Journal:  J Invest Dermatol       Date:  2014-07-18       Impact factor: 8.551

3.  Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin.

Authors:  G Neufang; G Furstenberger; M Heidt; F Marks; K Müller-Decker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

4.  p53 and MDM2 protein expression in actinic cheilitis.

Authors:  Maria da Conceição Andrade de Freitas; Luciana Maria Pedreira Ramalho; Flávia Caló Aquino Xavier; André Luis Gomes Moreira; Sílvia Regina Almeida Reis
Journal:  J Appl Oral Sci       Date:  2008 Nov-Dec       Impact factor: 2.698

5.  Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.

Authors:  K-T Kuo; H-C Chang; C-H Hsiao; M-C Lin
Journal:  Br J Ophthalmol       Date:  2006-03-15       Impact factor: 4.638

6.  Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma.

Authors:  Cem Leblebici; Esra Pasaoglu; Canan Kelten; Seher Darakci; Nevra Dursun
Journal:  Oncol Lett       Date:  2017-03-01       Impact factor: 2.967

7.  Nobiletin-loaded composite penetration enhancer vesicles restore the normal miRNA expression and the chief defence antioxidant levels in skin cancer.

Authors:  Mahitab Bayoumi; Mona G Arafa; Maha Nasr; Omaima A Sammour
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

8.  Clinical, histopathological and immunohistochemical study of keratoacanthoma.

Authors:  Alina Maria Vîlcea; Loredana Elena Stoica; Claudia Valentina Georgescu; Florina Carmen Popescu; Raluca Niculina Ciurea; Ionică Daniel Vîlcea; Cecil Sorin Mirea
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

Review 9.  Molecular markers associated with potentially malignant oral lesions (Review).

Authors:  Oana Mihaela Condurache Hritcu; Ana Emanuela Botez; Doinita Temelie Olinici; P Onofrei; Laura Stoica; V B Grecu; Paula Mihaela Toader; Laura Gheucă-Solovăstru; Elena Carmen Cotrutz
Journal:  Exp Ther Med       Date:  2021-06-04       Impact factor: 2.447

10.  Reduced P53 Staining in Actinic Keratosis is Associated with Squamous Cell Carcinoma: A Preliminary Study.

Authors:  Pimentel Dr Neto; Mma Alchorne; Ns Michalany; Mamm Abreu; Rc Borra
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.